About Novitium Pharma
Novitium Pharma is a Healthcare company based in East Windsor (United States) founded in 2016 by Muthusamy Shanmugam, and was acquired by ANI Pharmaceuticals in March 2021. Generic prescription medications are developed, manufactured, and distributed. The company has 111 employees. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.
Company details
Novitium Pharma was founded in 2016 in East Windsor, United States, within the pharmaceutical sector. Generic prescription medications are developed, manufactured, and distributed by the company, with emphasis on various therapeutic categories and dosage forms. Operations are supported by a team of scientists and engineers, covering research, production, and market delivery while adhering to quality standards for safety and efficacy.
- Headquarters East Windsor, United States
- Employees 111
- Founders Muthusamy Shanmugam
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website novitiumpharma.com
- Acquired by ANI Pharmaceuticals (Mar 2021)
- Annual Revenue$1.16 M (USD)74as on Mar 31, 2022
- Net Profit$129.47 K (USD)188as on Mar 31, 2022
- Investors
- Employee Count111
- Acquired byANI Pharmaceuticals
(Mar 2021)
Investors in Novitium Pharma
Novitium Pharma has secured backing from 1 investor. Prominent investors backing the company include ANI Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Branded and generic prescription drugs are developed, manufactured, and marketed. | 1996 | anipharmaceuticals.com | Baudette, United States |
Investor details for Novitium Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Novitium Pharma
1 people are tracked at Novitium Pharma (1 in leadership); the tracked headcount is 111.
| Name | Role | Group |
|---|---|---|
Muthusamy Shanmugam | Founder & President | Leadership |
Complete people profiles for Novitium Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Novitium Pharma
2 dated milestones of Novitium Pharma across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Novitium Pharma is founded.
- Exit Acquired by ANI Pharmaceuticals.
Web traffic of Novitium Pharma
The website of Novitium Pharma (novitiumpharma.com) receives about 1.8K visits a month.
- Monthly visits1.8K
▲ 79.2% vs previous month
Websites whose visitors overlap most with Novitium Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
medvacon.com | medvacon.com | 100% | #11,080,893 | – | |
| agiletherapeutics.com | 98% | View details | |||
| iviewtherapeutics.com | 95% | 1.9K | #10,588,463 | View details | |
| genesisbiotechgroup.com | 94% | #5,382,456 | View details | ||
| akrospharma.com | 92% | 1.5K | #10,598,752 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for Novitium Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Novitium Pharma (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Novitium Pharma
Complete news archive for Novitium Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Novitium Pharma
Novitium Pharma was founded in 2016.
Novitium Pharma is headquartered in East Windsor, United States. It is registered at East Windsor, New Jersey, United States.
Novitium Pharma has 111 employees.
Annual revenue of Novitium Pharma is $1.16M as on Mar 31, 2022.
Novitium Pharma was founded in 2016 in East Windsor, United States, within the pharmaceutical sector. Generic prescription medications are developed, manufactured, and distributed by the company, with emphasis on various therapeutic categories and dosage forms. Operations are supported by a team of scientists and engineers, covering research, production, and market delivery while adhering to quality standards for safety and efficacy.
Novitium Pharma has 1 investor. Key investors include ANI Pharmaceuticals.
Yes. Novitium Pharma was acquired by ANI Pharmaceuticals in March 2021.